As part of the Prime Minister’s vision for a healthier and more inclusive India, GAIL, in collaboration with AIIMS Delhi, launched a CSR initiative on March 24, 2025, to provide recombinant human growth hormone (rhGH) therapy to pediatric patients with growth hormone deficiency (GHD).
The event was attended by Ms. Bansuri Swaraj, MP, and AIIMS Institute Body Member, Mr. Ayush Gupta, Director (HR), GAIL, and Mr. M. Srinivas, Director, AIIMS, reinforcing their commitment
This initiative removes financial barriers, ensuring children receive critical rhGH therapy to support growth and well-being. Through this effort, GAIL and AIIMS contribute to a healthier India, where every child can thrive.
